Royal Bank of Canada’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Buy |
|
|||||
|
2025
Q1 | $6K | Sell |
|
|||||
|
2024
Q4 | $24K | Buy |
|
|||||
|
2024
Q3 | $43K | Buy |
|
|||||
|
2024
Q2 | $32K | Buy |
|
|||||
|
2024
Q1 | $15K | Sell |
|
|||||
|
2023
Q4 | $102K | Buy |
|
|||||
|
2023
Q3 | $30K | Buy |
|
|||||
|
2023
Q2 | $49K | Buy |
|
|||||
|
2023
Q1 | $41K | Sell |
|
|||||
|
2022
Q4 | $234K | Buy |
|
|||||
|
2022
Q3 | $103K | Buy |
|
|||||
|
2022
Q2 | $100K | Sell |
|
|||||
|
2022
Q1 | $433K | Sell |
|
|||||
|
2021
Q4 | $1.58M | Buy |
|
|||||
|
2021
Q3 | $633K | Sell |
|
|||||
|
2021
Q2 | $13.1M | Buy |
|
|||||
|
2021
Q1 | $2.83M | Buy |
|
|||||
|
2020
Q4 | $18K | Sell |
|
|||||
|
2020
Q3 | $35K | Buy |
|
|||||
|
2020
Q2 | $16K | Buy |
|
|||||
|
2020
Q1 | $6K | Sell |
|
|||||
|
2019
Q4 | $42K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $0 | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $24K | Buy |
|
|||||
|
2018
Q2 | $1K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $0 | Sell |
|
|||||
|
2017
Q3 | $14K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $0 | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1K | Sell |
|
|||||
|
2015
Q2 | $3K | Buy |
|